CONVERGEN
Live / Applied — Suspended — suspension letter mailed (as of 05 Nov 2025)
What this means for you
Not registered yet, but its 13 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99040419
- Mark type
- Stylized text
- Filed
- 13 Feb 2025
- Attorney of record
- Michael J Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations and agents for the prevention and treatment of diabetes and metabolic diseases/disorders; chemical and biological preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of endocrinological diseases and disorders
- Class 042 — Scientific and technological services: medical research services; medical research laboratory services; pharmaceutical research and development services; medical and scientific research information in the field of healthcare; scientific and technological product research services for others in the field of diabetes
Owner
- Convergen Biotech, Inc., Austin, TX, US
Prosecution history
- 05 Nov 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 05 Nov 2025 — LETTER OF SUSPENSION E-MAILED
- 05 Nov 2025 — SUSPENSION LETTER WRITTEN
- 04 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Aug 2025 — NON-FINAL ACTION E-MAILED
- 05 Aug 2025 — NON-FINAL ACTION WRITTEN
- 22 Jul 2025 — ASSIGNED TO EXAMINER
- 09 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Feb 2025 — NEW APPLICATION ENTERED